Clinical trials
Completed Renal Insufficiency trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
899 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 10 |
| 2003 | 28 |
| 2004 | 25 |
| 2005 | 18 |
| 2006 | 30 |
| 2007 | 24 |
| 2008 | 54 |
| 2009 | 36 |
| 2010 | 50 |
| 2011 | 58 |
| 2012 | 43 |
| 2013 | 45 |
| 2014 | 42 |
| 2015 | 44 |
| 2016 | 42 |
| 2017 | 52 |
| 2018 | 35 |
| 2019 | 39 |
| 2020 | 23 |
| 2021 | 39 |
| 2022 | 36 |
| 2023 | 40 |
| 2024 | 38 |
| 2025 | 16 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 899 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 24 |
| AstraZeneca | 19 |
| Merck Sharp & Dohme LLC | 17 |
| Pfizer | 16 |
| Astellas Pharma Inc | 13 |
| Akebia Therapeutics | 11 |
| GlaxoSmithKline | 11 |
| Bayer | 10 |
| Boehringer Ingelheim | 10 |
| Fresenius Medical Care Deutschland GmbH | 10 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Renal Insufficiency | 899 |
| Kidney Failure, Chronic | 112 |
| Renal Insufficiency, Chronic | 96 |
| Kidney Diseases | 85 |
| Heart Failure | 45 |
| Acute Kidney Injury | 41 |
| Anemia | 33 |
| Diabetes Mellitus, Type 2 | 26 |
| Diabetes Mellitus | 22 |
| Multiple Myeloma | 19 |
Trials
Showing 26 to 50 of 899. Each trial links to its page on Pharma Observatory.
799 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.